QQ客服 官方微博 反馈留言

	LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis
	Wang, Hongxiang; Song, Xiao; Huang, Qilin; Xu, Tao; Yun, Dapeng; Wang, Yuqi; Hu, Lingna; Yan, Yong; Chen, Hongyan; Lu, Daru
刊名	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
	2019
卷号	28期号:4
ISSN号	1055-9965
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3598458
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Hongxiang,Song, Xiao,Huang, Qilin,et al. LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION,2019,28(4).
APA	Wang, Hongxiang.,Song, Xiao.,Huang, Qilin.,Xu, Tao.,Yun, Dapeng.,...&Chen, Juxiang.(2019).LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION,28(4).
MLA	Wang, Hongxiang,et al."LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis".CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 28.4(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。